Latha Vairavan, SVP Chief Financial Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 88 shares at $24.72 ($2K) on 2025-11-03, disclosed to the SEC on 2025-11-05.
Open-market sale of $2k ARQT by SVP Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ARQT | SELL | 2026-03-03 | $144K | — | Filing → |
| ARQT | SELL | 2026-02-04 | $34K | — | Filing → |
| ARQT | SELL | 2025-08-05 | $1K | — | Filing → |